Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isotretinoin for COVID-19 Prevention and Vaccine Enhancement
NCT04730895Phase 2Unknown
- Sponsor
- Kafrelsheikh University
- Start
- Jul 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of isotretinoin in coronavirus disease 2019 (COVID-19), sponsored by Kafrelsheikh University. Status: unknown.
02
Drugs
isotretinoin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04730895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04730895.